Skip to main content

How wine helps diabetes

If current trends continue, an epidemic of diabetes is looming over the country. Are wine drinkers exempt? There is good evidence that wine drinkers are less likely to develop type 2 (non insulin-dependent) diabetes, and recent research may help explain why: wine derived compounds work in much the same way as popular diabetes medications.


To begin with, type 2 diabetes is typically associated with obesity, a main reason for the upward trend in developed countries. Wine drinkers tend to have healthier lifestyles overall so a certain amount of the benefit relates to healthier eating and exercising regularly. However, there seems to be more to it than that, and now we have biochemical evidence to back us up. One way that diabetes drugs work is to make cells more sensitive to insulin, which in turn helps them take in sugar. (Type 2 diabetics have a problem with insulin sensitivity, not a lack of insulin as in type 1.) Fat cells in particular become resistant to insulin.

Diabetes drugs such as Avandia (rosiglitazone) make cells more responsive to insulin by binding a receptor call PPAR. Red wine contains at least 2 compounds, ellagic acid and epicatechin gallate, that also bind PPAR. On average, a glass of red wine is equivalent (experimentally) to a full dose of Avandia (which by the way cautions against taking it with alcohol.) Other studies have found resveratrol from red wine to have anti-diabetic effects.

Of course anyone on diabetes medication should discuss their alcohol consumption with their doctor, but it helps to be independently informed as well. Alcohol, despite the calories, is metabolized differently from carbohydrates such as sugar; so wine, whose only calories come from alcohol, is less likely to cause problems with blood sugar levels.

Comments

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

Should wine labels make health claims?

Winemakers have been in a debate for some years now with the U.S. Department of Treasury's Alcohol, Tax and Trade Bureau (formerly the ATF, for Alcohol, Tobacco, and Firearms--yeah, that made a lot of sense) about ingredient listing for wines, particularly since the healthful properties of wine polyphenols such as resveratrol have been widely publicised. A couple of years back, an Oregon pinot noir producer gained approval for a fairly benign claim: "Pinot noir develops a natural defense against botrytis (mold) in our moist, cool climate - the antioxidant resveratrol." Since resveratrol is indeed produced in the skins of grapes subjected to certain environmental stresses such as mold, and Oregon's climate is certifiably moist, it seems a fairly harmless claim. However, the feds simultaneously disallowed placing the same wording on another vintage from the same producer, citing concern about making therapeutic claims on labels or creating "misleading" associa...